ClinTec International expands further in MENA region with proposed opening of Istanbul office

ClinTec International will formally open an office in Istanbul, Turkey. The office will not only provide ClinTec’s global team with access to a new patient population, but will also further consolidate the British CRO’s presence in the Middle East and North Africa (MENA) region. The office adds to the company’s current MENA region offices based in Cairo, Egypt, Dubai Health Care City, UAE, and Beirut, Lebanon.

Speaking at the announcement of ClinTec’s new office, Dr Rabinder Buttar, Founder and Chief Executive Officer, ClinTec International said, “The launch of this new office in Turkey confirms ClinTec International’s reputation as a truly global provider of quality assured clinical research services. It also reflects the growing significance of Turkey- and the wider MENA region- to the global clinical research market. We are delighted to be at the forefront of developing expertise in Turkey and the MENA region as a whole.”

The announcement of ClinTec’s new Turkey office coincides with the company sponsoring the Partnerships in Clinical Trials Russia-CIS & MENA-Turkey conference to be held in Istanbul on May 22 and 23, 2013. The conference aims to explore the challenges and opportunities facing companies when conducting clinical trials in the MENA region, and looks for the leading CROs within the region to provide solutions and advice on this complex market. As such, Bindhya Cariappa, Executive Vice-President- Global Clinical Development ClinTec’s will be delivering a speech on Rare Disease Trials in the MENA region.

EP News Bureau– Mumbai